uniQure (QURE) EBT Margin (2016 - 2026)

uniQure's (QURE) quarterly EBT Margin came in at 1489.25% in Q1 2026, up 126385.0% year-on-year from N/an in Q1 2025, and down 102.24% quarter-over-quarter from 736.39% in Q4 2025.

uniQure (QURE) EBT Margin (2016 - 2026) Analysis & Trends

uniQure's EBT Margin history runs 11 years deep, the most recent figure standing at 1489.25% for Q1 2026.

  • On a quarterly basis, EBT Margin rose 126385.0% year-over-year to 1489.25% in Q1 2026; TTM through Mar 2026 was 1123.34%, a 5752.0% decrease from a year earlier, with the FY2025 full-year figure at 1201.02%, down 32662.0% from the prior year.
  • EBT Margin declined to 1489.25% in Q1 2026 per QURE's latest filing, from 736.39% in the prior quarter.
  • Across five years, EBT Margin topped out at 6.42% in Q4 2022 and bottomed at 7923.34% in Q2 2022.
  • The 5-year median for EBT Margin is 1489.25% (2026), against an average of 2224.53%.
  • Biggest YoY gain for EBT Margin was 646721 bps in 2022; the steepest drop was 801016 bps in 2022.
  • Year by year, EBT Margin stood at 6.42% in 2022, then tumbled by 16431 bps to 1049.07% in 2023, then plunged by 32 bps to 1386.8% in 2024, then jumped by 47 bps to 736.39% in 2025, then slumped by 102 bps to 1489.25% in 2026.
  • Per Business Quant, the three latest QURE EBT Margin figures stand at 1489.25% (Q1 2026), 736.39% (Q4 2025), and 1942.8% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn -1,489.25%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,489.25%
Dec 31, 2025 -736.39%
Sep 30, 2025 -1,942.80%
Jun 30, 2025 -708.74%
Mar 31, 2025 -2,753.10%
Dec 31, 2024 -1,386.80%
Sep 30, 2024 -1,941.80%
Jun 30, 2024 -497.49%
Mar 31, 2024 -765.61%
Dec 31, 2023 -1,049.07%
Sep 30, 2023 -6,371.00%
Jun 30, 2023 -2,820.44%
Mar 31, 2023 -1,472.94%
Dec 31, 2022 6.42%
Sep 30, 2022 -3,325.47%
Jun 30, 2022 -7,923.34%
Mar 31, 2022 -2,639.17%
Dec 31, 2021 13.63%
Sep 30, 2021 -1,832.18%
Jun 30, 2021 86.82%